Literature DB >> 18396300

5HT2 receptor activation facilitates P2X receptor mediated excitatory neurotransmission to cardiac vagal neurons in the nucleus ambiguus.

Olga Dergacheva1, Xin Wang, Harriet Kamendi, Qi Cheng, Ramon Manchon Pinol, Heather Jameson, Christopher Gorini, David Mendelowitz.   

Abstract

Parasympathetic preganglionic cardiac vagal neurons (CVNs) which dominate the control of heart rate are located within the nucleus ambiguus (NA). Serotonin (5HT), and in particular 5HT2 receptors, play an important role in cardiovascular function in the brainstem. However, there is a lack of information on the mechanisms of action of 5HT2 receptors in modulating parasympathetic cardiac activity. This study tests whether activation of 5HT2 receptors alters excitatory glutamatergic and purinergic neurotransmission to CVNs. Application of alpha-methyl-5-hydroxytryptamine (alpha-Me-5HT), a 5HT2 agonist, reversibly increased both the frequency and amplitude of miniature excitatory postsynaptic currents (mEPSCs) in CVNs. Similar responses were obtained with alpha-methyl-5-(2-thienylmethoxy)-1H-indole-3-ethanamine hydrochloride (BW723C86), and m-chlorophenylpiperazine (m-CPP), 5HT2B and 5HT2B/C receptor agonists, respectively. The facilitation evoked by alpha-Me-5HT was prevented by the 5HT2B/C receptor antagonist SB206553 hydrochloride (SB206553). Interestingly, the blockage of both NMDA and non-NMDA glutamatergic receptors did not prevent alpha-Me-5HT-evoked facilitation of mEPSCs, however, the responses were blocked by the P2 receptor antagonist pyridoxal-phosphate-6-azophenyl-2',4'-disulfonic acid (PPADS). The responses evoked by alpha-Me-5HT were mimicked by application of alpha,beta-methylene ATP (alpha,beta-Me-ATP), a P2X receptor agonist, which were also blocked by PPADS. In summary, these results indicate activation of 5HT2 receptors facilitates excitatory purinergic, but not glutamatergic, neurotransmission to CVNs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18396300      PMCID: PMC2442471          DOI: 10.1016/j.neuropharm.2008.02.016

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  34 in total

Review 1.  Central cardiovascular regulation and 5-hydroxytryptamine receptors.

Authors:  A G Ramage
Journal:  Brain Res Bull       Date:  2001-11-15       Impact factor: 4.077

2.  Arginine vasopressin enhances GABAergic inhibition of cardiac parasympathetic neurons in the nucleus ambiguus.

Authors:  J Wang; M Irnaten; P Venkatesan; C Evans; D Mendelowitz
Journal:  Neuroscience       Date:  2002       Impact factor: 3.590

3.  In vivo modulation of vagal-identified dorsal medullary neurones by activation of different 5-Hydroxytryptamine(2) receptors in rats.

Authors:  C Sévoz-Couche; K M Spyer; D Jordan
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

Review 4.  Serotonin2 receptors in the nucleus tractus solitarius: characterization and role in the baroreceptor reflex arc.

Authors:  Laguzzi Raul
Journal:  Cell Mol Neurobiol       Date:  2003-10       Impact factor: 5.046

5.  Differential increases in P2X receptor levels in rat vagal efferent neurones following a vagal nerve section.

Authors:  Lucy Atkinson; Eiji Shigetomi; Fusao Kato; Jim Deuchars
Journal:  Brain Res       Date:  2003-07-04       Impact factor: 3.252

6.  ATP is a mediator of chemosensory transduction in the central nervous system.

Authors:  Alexander V Gourine; Enrique Llaudet; Nicholas Dale; K Michael Spyer
Journal:  Nature       Date:  2005-07-07       Impact factor: 49.962

7.  Modulation of reflexly evoked vagal bradycardias by central 5-HT1A receptors in anaesthetized rabbits.

Authors:  Matthew R Skinner; Andrew G Ramage; David Jordan
Journal:  Br J Pharmacol       Date:  2002-11       Impact factor: 8.739

8.  The role of central 5-HT(1A) receptors in the control of B-fibre cardiac and bronchoconstrictor vagal preganglionic neurones in anaesthetized cats.

Authors:  Y Wang; A G Ramage
Journal:  J Physiol       Date:  2001-11-01       Impact factor: 5.182

9.  Purinergic modulation of cardiovascular function in the rat locus coeruleus.

Authors:  Song T Yao; Andrew J Lawrence
Journal:  Br J Pharmacol       Date:  2005-06       Impact factor: 8.739

10.  Presynaptic release of ATP from superior cervical ganglion of rats modulated by various receptors.

Authors:  S D Liang; E S Vizi
Journal:  Zhongguo Yao Li Xue Bao       Date:  1999-07
View more
  5 in total

1.  5HT1A receptors inhibit glutamate inputs to cardiac vagal neurons post-hypoxia/hypercapnia.

Authors:  Olga Dergacheva; Harriet W Kamendi; Xin Wang; David Mendelowitz
Journal:  Respir Physiol Neurobiol       Date:  2011-09-14       Impact factor: 1.931

2.  5-HT2 receptors modulate excitatory neurotransmission to cardiac vagal neurons within the nucleus ambiguus evoked during and after hypoxia.

Authors:  O Dergacheva; H Kamendi; X Wang; R A Pinol; J Frank; C Gorini; H Jameson; M R Lovett-Barr; D Mendelowitz
Journal:  Neuroscience       Date:  2009-09-20       Impact factor: 3.590

3.  Severe spontaneous bradycardia associated with respiratory disruptions in rat pups with fewer brain stem 5-HT neurons.

Authors:  Kevin J Cummings; Kathryn G Commons; Kenneth C Fan; Aihua Li; Eugene E Nattie
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-04-15       Impact factor: 3.619

4.  The role of 5-HT3 and other excitatory receptors in central cardiorespiratory responses to hypoxia: implications for sudden infant death syndrome.

Authors:  Olga Dergacheva; Harriet Kamendi; Xin Wang; Ramon Manchon Pinol; Julie Frank; Heather Jameson; Christopher Gorini; David Mendelowitz
Journal:  Pediatr Res       Date:  2009-06       Impact factor: 3.756

5.  Intrapulmonary arteries respond to serotonin and adenosine triphosphate in broiler chickens susceptible to idiopathic pulmonary arterial hypertension.

Authors:  H A Kluess; J Stafford; K W Evanson; A J Stone; J Worley; R F Wideman
Journal:  Poult Sci       Date:  2012-06       Impact factor: 3.352

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.